<DOC>
	<DOCNO>NCT02786667</DOCNO>
	<brief_summary>Clinical description pathophysiological study recently diagnose untreated patient Parkinson 's Disease . Effect dopamine agonist ( rotigotine ) apathy de novo patient Parkinson disease : A control , randomize , double blind study .</brief_summary>
	<brief_title>Non Motors Aspects De Novo Parkinson 's Disease</brief_title>
	<detailed_description>This study aim show impact treatment D2/D3 receptor-specific dopamine agonist hypo-dopaminergic syndrome quality life patient de-novo Parkinson 's disease . The study consist three part : 1 . The first part consist detailed clinical description patient , focus neuropsychological symptom . The objective describe patient without apathy hypo-dopaminergic syndrome . 2 . From population , small number patient without hypo-dopaminergic syndrome select order compare serotoninergic dopaminergic denervation positron emission tomography ( PET ) . 3 . In patient hypo-dopaminergic syndrome motivational effect dopamine agonist test randomize , double-blind , placebo-controlled study . We hypothesize significant improvement apathy rotigotine group versus placebo</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Patients Parkinson disease without treatment Parkinson disease Recent diagnosis ( &lt; 2 year ) Without cognitive trouble Patients cognitive trouble Treated patient LDopa Dopamine agonists Other severe illness Pregnant parturient woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>